AIM ImmunoTech (AIM) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

AIM is expected to report earnings to rise 100.00% to -5 cents per share on November 15

AIM ImmunoTech AIM Stock Earnings Reports

Q3'24

Est.

$-0.06

Q2'24

Beat

by $0.09

Q1'24

Est.

$-0.12

Q4'23

Missed

by $0.14

Q3'23

Missed

by $0.05

The last earnings report on August 16 showed earnings per share of -2 cents, beating the estimate of -11 cents. With 310.34K shares outstanding, the current market capitalization sits at 15.43M.

View a ticker or compare two or three

Compare

AIM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For AIM
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2117 SW Highway 484

Phone

+1 352 448-7797

Employees

Web

https://www.aimimmuno.com